Primer composition and application thereof

The invention discloses a primer composition and an application thereof. The primer composition comprises a reverse transcription primer of at least one of hsa-miR-133a, hsa-miR-141, hsa-miR-143 #, hsa-miR-151-5p, hsa-miR-29c, hsa-miR-429 and hsa-miR-96, a forward primer of fluorescent quantitative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHANG FENGWU, WU HONGFEI, WANG HAILONG, ZHU MIAOJUN, TAN RUOYING
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses a primer composition and an application thereof. The primer composition comprises a reverse transcription primer of at least one of hsa-miR-133a, hsa-miR-141, hsa-miR-143 #, hsa-miR-151-5p, hsa-miR-29c, hsa-miR-429 and hsa-miR-96, a forward primer of fluorescent quantitative PCR (Polymerase Chain Reaction), a reverse primer of fluorescent quantitative PCR, and a probe of fluorescent quantitative PCR. The primer composition provided by the invention can be used for detecting the expression level of seven miRNAs. When the primer composition is used for determining the expression levels of the seven miRNAs, high sensitivity, specificity and accuracy are achieved, and operation is easy, convenient and rapid. Furthermore, whether a patient suffers from the urinary tract epithelial cell carcinoma or not is evaluated through the expression levels of the seven miRNAs, and the miRNAs can be further used for diagnosing the urinary tract epithelial cell carcinoma. 本申请公开了一种引物组合物及其应用,所述引物组合物包含hsa-m